Varinder Kaur headshot
VK

Varinder Kaur

Assistant Professor
Unit: School of Medicine
Department: Department of Medicine, Hematology and Oncology
Office location and address
Emily Couric Clinical Cancer Center
1335 Lee St
Charlottesville, Virginia 22903
Education
Government Medical College and Hospital, MD
Residency, University of Arkansas
Fellowship, University of Arkansas
PDS0101 (ImmunoMAPK - RDOTAP/HPV-16 E6 & E7 Peptides) and Pembrolizumab (KEYTRUDA®) Combination Immunotherapy as a First Line Treatment in Subjects with Recurrent and/or Metastatic Head and Neck Cancer and High-Risk Human Papillomavirus-16
Source: PDS Biotechnology Corporation
August 26, 2021 – August 25, 2024
Protocol 9950: A Phase I Study of VX-970 in Combination with Cisplatin and XRT in Patients with Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma
Source: Johns Hopkins University, The
October 15, 2017 – February 28, 2023
MD-INMD-HO Kaur Merck 34785-689
Source: Merck Sharp & Dohme Corp.
June 12, 2018 – June 11, 2022
MD-INMD-HO A Randomized Phase III study of pembrolizumab given concomitantly with chemoradiation and as maintenance therapy versus chemoradiation alone in subjects with locally advanced head and neck squamous cell carcinoma
Source: Merck Sharp & Dohme Corp.
June 07, 2017 – June 06, 2022
MD-INMD-HO - Kaur - Aspyrian 1929-301
Source: Rakuten Aspyrian, Inc.
May 31, 2019 – May 30, 2022
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin
Source: NRG Oncology Foundation, Inc.
March 20, 2018 – March 19, 2022
MD-INMD-HO - Kaur - Soligenix IDR-OM-02
Source: Soligenix, Inc.
March 05, 2019 – March 04, 2022
MD-INMD-HO Kaur BMS CA209-9NA
Source: ICON CLINICAL RESEARCH, INC.
March 01, 2018 – February 28, 2019
A Phase I Study of VX-970 in Combination with Cisplatin and XRT in Patients with Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma
Source: Johns Hopkins University, The
October 15, 2017 – October 15, 2017